Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 3, 2008, Pages 1020-1029

  Robinson White, Audrey J ^a   Hsiao, Hui Pin ^a,d   Leitner, Wolfgang W ^b   Greene, Elizabeth ^a   Bauer, Andrew ^a   Krett, Nancy L ^c   Nesterova, Maria ^a   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

8 CL ADENOSINE; 8 CL CYCLIC AMP; ANTINEOPLASTIC AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOBUTYLMETHYLXANTHINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN CELL; PKA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID CANCER;

EID: 40849104803     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2331     Document Type: Article

References (40)

1. Sakamoto A 2004 Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience. Endocr Pathol 15:307-311
2. Nikiforov YE 2004 Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 15:319-327
3. Delellis RA, Lloyd RV, Hertz PU, Eng C 2004 Tumors of the thyroid and parathyroid. In: Delellis RA, Lloyd RV, Hertz PU, Eng C, eds. WHO classification of tumors: pathology and genetics. Lyon, France: IARC Press; 51-80
4. Liska J, Altanerova V, Galbavy S, Stvrtina S, Brtko J 2005 Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr Res 39:73-83
5. Ain KB 1998 Anaplastic thyroid carcinoma: behavior, biology and therapeutic approaches. Thyroid 8:715-726
6. Robinson-White A, Stratakis CA 2002 Protein kinase A signaling: "cross talk" with other pathways in endocrine cells. Ann NY Acad Sci 968:256-270
7. Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F, Stratakis CA 2003 Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Hum Mol Genet 12:1475-1484
8. Tasken K, Shalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Larsen T, Johansen AK, Vang T, Scharder HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T 1997 Structure, function and regulation of human cAMP-dependent protein kinase. Adv Second Messenger Prosphoprotein Res 31:191-204
9. Scott JD 1991 Cyclic nucleotide-dependent protein kinase. Pharmacol Ther 50:123-145
10. Robinson-White AJ, Leitner WW, Aleem E, Kaldis P, Bossis I, Stratakis CA 2006 PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes. Cancer Res 66:10603-10612
11. Katsaros D, Tortora G, Tagliaferri P, Clair T, Ally S, Neckers L, Robins RK, Cho-Chung YS 1987 Site-selective cyclicAMPanalogs provide a new approach in the control of cancer cell growth. FEBS Lett 223:97-103
12. Ally S, Tortora G, Clair T, Grieco D, Merlo G, Katsaros D, Ogreid D, Doskeland SO, Jahnsen T, Cho-Chung YS 1988 Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadensoine 3′,5′-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc Natl Acad Sci USA 85:6319-6322
13. Rohlff C, Clair T, Cho-Chung YS 1993 8-Cl-cAMP induces truncation and downregulation of the RI α-subunit and up-regulation of the RII β-subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem 268:5774-5782
14. Bennett Jr LL, Chang C-H, Allan PW, Adamson DJ, Rose LM, Brockman RW, Secrist III JA, Shortnacy A, Montgomery JA 1985 Metabolism and metabolic effects of halopurine nucleosides in tumor cells in culture. Nucleotides 4:107-116
15. Gandhi V, Ayers M, Halgren RG, Krett NL, Newman RA, Rosen ST 2001 8-Chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res 61:5474-5479
16. Langeveld CH, Jongenelen CAM, Theeuwes JWM, Baak JPA, Heimans JJ, Stoff JC, Peters GJ 1997 The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate and disturbances in nucleic acid synthesis and cell cycle kinetics. Biochem Pharm 53:141-148
17. Langeveld CH, Jongenelen CAM, Heimans JJ, Stoff JC 1992 Growth inhibition of human glioma cells induced by 8-chloroadenosine, an active metabolite of 8-chloro adenosine 3′:5′-monophosphate. Cancer Res 52:3994-3999
18. Robbins SK, Houlbrook S, Priddle JD, Harris AL 2001 8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs. Cancer Chemother Pharmacol 48:451-458
19. Halgren RG, Traynor AE, Pillay S, Zell JL, Heller KF, Krett NL, Rosen ST 1998 8 Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosine. Blood 92:2893-2898
20. Phillips E, Newsholme EA 1979 Maximum activities, properties and distribution of 5′-nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J Neurochem 33:553-558
21. Stellrecht CM, Rodriguez Jr CO, Ayres M, Gandhi V 2003 RNA-directed actions of 8-chloro-adenosine in multiple myeloma cells. Cancer Res 63:7968-7974
22. Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, Hong SH 2001 8-ClcAMP induces cell cycle specific apoptosis in human cancer cells. Int J Cancer 93:33-41
23. Zhang S, Zheng D, Liu S 1998 [8 Chloro-adenosine induced apoptosis in various human tumor cell lines]. Zhonghua Zhong Liu Za Zhi (Chinese) 20:88-89
24. Yin Y, Allen PD, Jia I, Kelsey SM, Newland AC 2001 8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblast leukemia cells to TNFα-induced apoptosis is via inactivation of NF-kB. Leukemia Res 25:423-431
25. Dransfield DT, Griner RD, Ray S, Keskintepe M, Bollag WB 2001 8 Cl-adenosine induces growth arrest without differentiation of primary mouse epidermal keratinocytes. J Invest Dermatol 117:1588-1593
26. Asakawa H, Kobayashi T, Komoike Y, Yanagawa T, Takahashi M, Wakasugi E, Maruyama H, Tamaki Y, Matsuzawa Y, Monden M 1996 Establishment of anaplastic thyroid carcinoma cell lines for analysis of chemosensitivity and carcinogenesis. J Clin Endocrinol Metab 81:3547-3552
27. Yates CM, Patel A, Oakley K, Helms A, Tuttle RM, Francis GL 2006 Erythropoietin in thyroid cancer. J Endocrinol Invest 29:320-329
28. Homburg CH, deHass M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roo SD 1995 Human neutrophils lose their surface FcγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood 85:532-540
29. Robinson-White A, Meoli E, Stergiopoulos S, Horvath A, Boikos S, Bossis I, Stratakis CA 2006 PRKARIA mutation and protein kinase A interactions with other signaling pathways in the adrenal cortex. J Clin Endocrinol Metab 9:2380-2388
30. Vasko V, Saji M, Hardy E, Kruhlak M, Larin A, Savchenko V, Miyakawa M, Isozaki O, Murakami H, Tsushima T, Burman KD, DeMicco C, Ringel MD 2004 Akt activation and localization correlate with tumor invasion and oncogene expression in thyroid cancer. J Med Genet 41:161-170
31. Lamb D, Steinberg RA 2002 Anti-proliferative effects of 8-Chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression. J Cell Physiol 192:216-224
32. Taylor CW, Yeoman LC 1992 Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anticancer Drugs 3:485-491
33. Juranic Z, Radulovic S, Joksimovic J, Juranic I 1998 The mechanism of 8-Cl-cAMP action. J Exp Clin Cancer Res 17:269-275
34. 3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J Immunol Methods 187:85-93
35. Lange-Carter CA, Vuillequez JJ, Malkinson AM 1993 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism. Cancer Res 53:393-400
36. Han Z, Chatterjee D, Wyche JH 1993 Proliferation of nontransformed cells is inhibited by adenosine metabolite of but not by parental 8-Cl-cyclic AMP. J Pharmacol Exp Ther 265:790-794
37. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C 1995 A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expressiononearly apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 184:39-51
38. Williams M, Abreu M, Jarvis MF, Noronha-Blob L 1987 Characterization of adenosine receptors in the PC12 pheochromocytoma cell line using radioligand binding: evidence for A-2 selectivity. J Neurochem 48:498-502
39. Ramage AD, Langdon SP, Ritchie AA, Burn DJ, Miller WR 1995 Growth inhibition by 8-chlorocyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenographs is associated with selective modulation of protein kinaseA isozymes. Eur J Cancer 31A:969-973
40. Motti ML, Califano D, Troncone G, De Marco C, Migliaccio I, Palmieri E, Pezzullo L, Palombini L, Fusco A, Viglietto G 2005 Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. Am J Pathol 166:737-749